DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma
- 12 February 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 76, 28-36
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- DJ-1 as a human oncogene and potential therapeutic targetBiochemical Pharmacology, 2015
- Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2015
- Prognostic impact of lymph node metastasis in distal cholangiocarcinomaBritish Journal of Surgery, 2015
- DJ-1: a promising marker in metastatic uveal melanomaJournal of Cancer Research and Clinical Oncology, 2014
- Neuroprotective Function of DJ-1 in Parkinson’s DiseaseOxidative Medicine and Cellular Longevity, 2013
- DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancerJournal of Cancer Research and Clinical Oncology, 2012
- High levels of DJ‐1 protein in nipple fluid of patients with breast cancerCancer Science, 2012
- Clinical significance of DJ‐1 as a secretory molecule: retrospective study of DJ‐1 expression at mRNA and protein levels in ductal carcinoma of the breastHistopathology, 2012
- Differential LC−MS-Based Proteomics of Surgical Human Cholangiocarcinoma TissuesJournal of Proteome Research, 2009
- Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patientsBMC Cancer, 2008